bioSyntagma
Phoenix
About bioSyntagma
BioSyntagma is a platform that generates a multi-omic, spatial cell profile to understand cancer in patients and provides an AI-based treatment plan. The company's contact modes are mail and physical address.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $1.4M
- Last round: Grant (Mar 2018)
- Website: biosyntagma.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Life Science
Social Profiles
Canonical: https://fsome.com/organization/biosyntagma-56636 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.